CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 195 filers reported holding CLOVIS ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,501,000 | +5.1% | 55,000 | +57.1% | 0.96% | +8.9% |
| Q4 2017 | $2,380,000 | -3.7% | 35,000 | +16.7% | 0.88% | +5.0% |
| Q3 2017 | $2,472,000 | +32.0% | 30,000 | +50.0% | 0.84% | +22.6% |
| Q2 2017 | $1,873,000 | +47.1% | 20,000 | 0.0% | 0.69% | +15.7% |
| Q1 2017 | $1,273,000 | +91.1% | 20,000 | +33.3% | 0.59% | +86.5% |
| Q4 2016 | $666,000 | – | 15,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |